Vaccine works on monkeys, now Oxford University is looking for people instead of big money for trials

BanglaHunt Desk: Corona vaccine has been tested in monkeys. This time Oxford University is looking for people instead of big money for trials.

Scientists and researchers around the world have begun developing vaccines to fight this deadly virus. In addition, many countries have demanded the development of vaccines. However, the vaccine has to go through several tests before it can hit the market. In this case, Oxford University in Britain is working the fastest. Last week, The university’s Jenner Institute has launched a human test of the coronary vaccine.

The institute wants to test more than 6,000 vaccines by May. The British government has promised to provide £ 200 million (Rs. 160 crore) to the institute for this. The institute has already tested a vaccine on Rhesus McCabe monkeys. The vaccine ‘ChAdOx1 nCoV-19’ has been shown to be effective in keeping monkeys infected with the coronavirus. Oxford University will conduct thousands of humanities tests in late May. According to a report in The New York Times, Britain is ahead in the race to develop vaccines. The same report claims that the Oxford-made vaccine has proven to be completely effective for rhesus macaque monkeys.

In fact, Oxford University tested its vaccine on monkeys in March at the Rocky Mountain Lab at the National Institutes of Health in Montana. The monkeys then came in contact with the corona virus. Some other monkeys were also infected with the corona virus. Studies have shown that vaccinated monkeys became very healthy even after about four weeks.

Even after 28 days, the 6 monkeys involved in the study recovered completely. Vincent Monster, who was involved in the study, said that all the monkeys were completely healthy 28 days after the vaccine test, while the other monkeys became ill. He added that the rhesus macaque monkeys included in the study are the closest to humans. The development of immunity against the coronavirus in Rhesus macaque monkeys from the vaccine does not mean a 100 percent guarantee of increased immunity in humans. Only these results have increased the excitement of taking the Oxford University vaccine test to the next level. Emilio Emini, director of the Bill & Melinda Gates Foundation's vaccine program, said Oxford University was working at a rapid pace in every way.

Hundreds of thousands of doses are expected to hit the market by September. According to The New York Times, millions of doses of the vaccine will be available by September, a few months ahead of all other countries. However, it is important that this vaccine is also effective in human trials. The Serum Institute of India is working closely with Oxford University to produce the vaccine. The institute has previously worked with Oxford University on a malaria vaccine project, said Ginger Punawala, chief executive officer (CEO) of the institute. We will also start testing this vaccine in India in the next two to three weeks. The production capacity for the first six months will be 50 lakh doses per month. After that, we will increase the production to one crore doses per month.